Russia to launch selection for Phase III innovative drug trial support in 2027

Russia's Ministry of Industry and Trade (Minpromtorg) will begin selecting projects for state compensation of Phase III clinical trial costs for innovative drugs, with the first selection in 2027. The regulatory framework is nearing final approval, according to Minister Anton Alihanov. This signals a continued state push to bolster domestic drug development, though details on funding and eligibility remain unclear.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works